The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAAA.L Regulatory News (AAA)

  • There is currently no data for AAA

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Statement re Announcement by Asimilar

3 Aug 2020 15:41

RNS Number : 9811U
All Active Asset Capital Limited
03 August 2020
 

3 August 2020

 

All Active Asset Capital Limited

('AAAC')

Statement re Announcement by Asimilar

The Board of AAAC notes that Asimilar Group plc ("Asimilar") has today made an announcement ("the Asimilar Announcement"), which has been reproduced below. AAAC's current investment portfolio includes equity, warrants and options over warrants in Asimilar. As noted in previous AAAC announcements, Asimilar's shares were suspended from trading on AIM on 14 February 2020, due to Asimilar seeking to make a potential investment in Sentiance NV ("Sentiance"). A summary of AAAC's interests in Asimilar is provided in AAAC's announcement of 26 June 2020.

The text of the Asimilar Announcement is reproduced below:

Asimilar Group plc

 

('Asimilar' or the 'Company')

 

Agreement with MESH Holdings plc

  

Further to its announcement on 14 July 2020, Asimilar Group plc (AIM: ASLR), the AIM quoted investing company focused on technology opportunities in the fields of big data, machine learning, telematics and the Internet of Things (IoT), is pleased to confirm it has reached a definitive agreement with MESH Holdings plc ('MESH') in relation to its proposed subscription in, and the granting of options over, the equity of Sentiance N.V. ('Sentiance').

 

The agreement provides that MESH will issue Asimilar with 24 million new ordinary shares in MESH credited as fully paid ('Consideration Shares') in consideration for the Company having assigned to MESH its interest and rights to subscribe for 10,000 new Sentiance shares at a price of €750 per share; to obtain an option to purchase 32,225 existing Sentiance shares at an exercise price of €650 per share; and to obtain a further option to subscribe for 10,000 new Sentiance shares at an exercise price of €750 per share, all as announced by Asimilar on 4 March 2020 (the 'Assignment').

 

The Assignment is conditional on the approval by MESH shareholders of resolutions to issue the new MESH shares, to be sought at the AGM of MESH to be held on 20 August 2020, which MESH convened following its announcement on 14 July of its offer to acquire 100% of Sentiance.

 

MESH currently has 246,090,166 ordinary shares in issue. Following the issue of the Consideration Shares, assuming no further shares are issued by MESH, Asimilar will hold approximately 8.89% of the enlarged issued share capital of MESH.

 

As a result of the Assignment, Asimilar has suspended its negotiations with Sentiance in relation to the proposals announced on 4 and 12 March 2020, pending completion of the Assignment following the MESH AGM.

 

It is anticipated that the suspension of trading in the Company's shares will be lifted following completion of the Assignment, which is subject to the passing of the necessary resolutions at the MESH AGM convened for 20 August 2020.

 

Rory O'Sullivan is a director of MESH, and has an interest in Asimilar shares representing 5.0% of its issued share capital. Robert Bonnier is a director of MESH. His wife, Nashida Islam Bonnier, has an interest in 14.8% of MESH's issued share capital and 2.6% of Asimilar's issued share capital. Mirador FZE has an interest in 8.5% of MESH's issued share capital and 9.5% of Asimilar's issued share capital. Chris Akers has an interest in 3.1% of MESH's issued share capital and 6.8% of Asimilar's issued share capital.

 

John Taylor, Chairman of Asimilar commented: "We are delighted to have finalised negotiations with MESH which have concluded with a deal that benefits all parties. Through our holding in MESH, we expect to benefit from a material economic interest in Sentiance without having had to subcribe directly into Sentiance, whilst MESH now has a clear route to complete its proposed acquisition of the entire share capital of Sentiance. We believe this arrangement will directly benefit Asimilar shareholders, given the size of our stake in MESH following the Assignment.

 

We look forward to tracking the progress of MESH and Sentiance closely, and will update shareholders with future developments."

 

 

For further information:

 

All Active Asset Capital Limited

James Normand, Non-Executive Chairman

Rodger Sargent, Executive Director

T: +44 (0) 7779 799431

www.aaacap.com

 

Allenby Capital Limited (Nominated Adviser and Broker)

Nick Athanas / Alex Brearley

T: +44 (0) 203 328 5656

www.allenbycapital.com

 

Buchanan (Financial PR)

Richard Oldworth / Chris Lane / Toto Berger

T: +44 (0) 207 466 5000

E: AAAC@buchanan.uk.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
STRFZGGRDFRGGZM
Date   Source Headline
14th Jul 20208:05 amRNSStatement re Announcement by Asimilar
9th Jul 20201:10 pmRNSBoard Appointment
2nd Jul 20209:20 amRNSBlock admission application
30th Jun 20203:10 pmRNSStatement re Asimilar Interim Results
26th Jun 20201:22 pmRNSExtension of reporting deadline & portfolio update
22nd Jun 20204:35 pmRNSPrice Monitoring Extension
19th Jun 20202:41 pmRNSHolding(s) in Company
18th Jun 20204:41 pmRNSSecond Price Monitoring Extn
18th Jun 20204:35 pmRNSPrice Monitoring Extension
17th Jun 202012:46 pmRNSHolding(s) in Company
16th Jun 20204:41 pmRNSSecond Price Monitoring Extn
16th Jun 20204:36 pmRNSPrice Monitoring Extension
16th Jun 20209:30 amRNSAdmission of Placing Shares and Board Change
12th Jun 202011:30 amRNSResult of Extraordinary General Meeting
28th May 20207:00 amRNSBoard changes
22nd May 20208:41 amRNSNotice of Extraordinary General Meeting
14th May 20204:40 pmRNSSecond Price Monitoring Extn
14th May 20204:35 pmRNSPrice Monitoring Extension
14th May 20204:22 pmRNSRevised placing to raise £1.2 million
14th May 20202:06 pmRNSSecond Price Monitoring Extn
14th May 20202:01 pmRNSPrice Monitoring Extension
14th May 202012:19 pmRNSOptions over warrants in Asimilar Group plc
7th May 20205:42 pmRNSFurther re. proposed conditional placing
28th Apr 20207:00 amRNSUpdate on proposed placing to raise £1.26 million
17th Apr 20202:57 pmRNSHolding(s) in Company
17th Apr 20202:52 pmRNSHolding(s) in Company
17th Apr 20202:50 pmRNSHolding(s) in Company
16th Apr 202011:53 amRNSHolding(s) in Company
14th Apr 20207:00 amRNSHolding(s) in Company
3rd Apr 20203:24 pmRNSProposed conditional placing
30th Mar 202012:10 pmRNSInvestment in shares in Asimilar Group Plc
26th Mar 20201:25 pmRNSHolding(s) in Company
20th Mar 20202:15 pmRNSInvestment in warrants in Asimilar Group Plc
10th Mar 202012:54 pmRNSChange of Board Roles
28th Feb 20205:00 pmRNSTotal Voting Rights
27th Feb 202012:58 pmRNSHolding(s) in Company
27th Feb 202012:58 pmRNSHolding(s) in Company
27th Feb 202011:13 amRNSHolding(s) in Company
24th Feb 202012:24 pmRNSResult of Extraordinary General Meeting
10th Feb 202011:01 amRNSAvailability of circular
5th Feb 20203:49 pmRNSProposed conditional placing to raise £200,000
31st Jan 202012:17 pmRNSBoard changes
15th Oct 20192:10 pmRNSChange of Name
10th Oct 201911:09 amRNSResult of Extraordinary General Meeting
30th Sep 20195:00 pmRNSTotal Voting Rights
24th Sep 20191:51 pmRNSInterim Results for the period ended 30 June 2019
23rd Sep 20191:00 pmRNSCompletion of placing and other matters
20th Sep 201911:04 amRNSAvailability of circular
17th Sep 201911:19 amRNSPlacing to raise £125,000 and other matters
30th Jul 20191:39 pmRNSResult of Annual General Meeting

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.